VEGFA and age-related macular degeneration: This suggests that ARMD RPE and aHUS podocytes are less efficient at inhibiting the alternative pathway at the cell surface and so could be more susceptible to reduction of CFH and other complement inhibitors mediated by VEGF antagonism.